The US healthcare system is facing significant caregiver capacity challenges. Over the years, the growing healthcare provider shortages have created an unsustainable burden on caregivers. Nationwide, the US is short of 110,000 physicians and 140,000 nurses.
The use of virtual care has skyrocketed over the past year. A survey by McKinsey and Company found that while virtual care utilization is beginning to level out, it remains 38 times higher than before the COVID-19 pandemic.
The COVID-19 pandemic led to drastic decreases in health spending over the last year as patients and providers were forced to delay routine care – leaving many hospital systems with significant revenue deficits. The Kaiser Family Foundation estimates that many hospitals will continue to face declining revenue amidst the lingering economic crisis. In these uncertain times, Hippo Virtual Care can help decrease hospitals’ overall costs, while simultaneously increasing revenue potential.
It comes as no surprise that the COVID-19 pandemic will have lasting impacts on healthcare systems worldwide. Seemingly overnight, healthcare delivery changed from in-person to digital, transforming the norm. Providers who had previously been slow to adopt virtual care models had to quickly scale up programs to reach patients and ensure the continuation of their clinics during a time of unprecedented change.
Virtual care is building a fifth wave of digital innovation in healthcare, enabling patients and providers more control over their data and care. Seattle-based Hippo Technologies, Inc. is revolutionizing virtual care and medical education with next-generation wearable technologies that transcend conventional boundaries, helping serve patients across the globe.
The way healthcare is delivered has gone through dramatic changes over the past few years, and these changes have been accelerated and cemented during the pandemic. With the increasing integration of technology and healthcare, data security is a growing concern for patients and providers alike.
Clinical trials are trying, even in normal times. The global pandemic has created a world of issues that exacerbate an already complex and inordinately long process. It has fueled massive disruptions that will inevitably have long-lasting effects on medical science.
As with life in general, the virus has severely affected the ability to conduct trials in safe and effective ways. An especially troubling fact when you consider that trials often deal with those vulnerable populations most at risk from exposure.
Hippo Technologies™ is working to support combat medics and soldiers to bring real-time access to the care they need, when and where they need it. Hippo’s hands-free voice-activated, head-worn tablet and Virtual Care Platform can bring the clinical specialist to the battlefield, no matter the distance or danger.
COVID-19 has compelled the medical community to adopt new technologies and telehealth. Even policymakers have recognized the need for flexibility at this time. But will these new policies be able to withstand “going back to normal”? Will this year’s success be enough to carry us forward to continue expanding telehealth and easier access? Over the […]